Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 2
1989 1
1990 1
1991 1
1992 3
1993 1
1994 4
1995 1
1996 1
1998 1
2000 2
2001 1
2002 2
2003 2
2004 2
2005 1
2006 1
2008 1
2015 1
2016 1
2017 1
2018 1
2019 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial.
Harbeck N, Fasching PA, Wuerstlein R, Degenhardt T, Lüftner D, Kates RE, Schumacher J, Räth P, Hoffmann O, Lorenz R, Decker T, Reinisch M, Göhler T, Staib P, Gluz O, Schinköthe T, Schmidt M; AGO-B WSG PreCycle investigators (see Appendix 1). Harbeck N, et al. Ann Oncol. 2023 Aug;34(8):660-669. doi: 10.1016/j.annonc.2023.05.003. Epub 2023 May 16. Ann Oncol. 2023. PMID: 37201751 Free article. Clinical Trial.
Why consider vaginal drug administration?
Alexander NJ, Baker E, Kaptein M, Karck U, Miller L, Zampaglione E. Alexander NJ, et al. Among authors: karck u. Fertil Steril. 2004 Jul;82(1):1-12. doi: 10.1016/j.fertnstert.2004.01.025. Fertil Steril. 2004. PMID: 15236978 Free article. Review.
Tamoxifen for breast cancer prevention.
Breckwoldt M, Karck U. Breckwoldt M, et al. Among authors: karck u. Exp Clin Endocrinol Diabetes. 2000;108(4):243-6. doi: 10.1055/s-2000-7751. Exp Clin Endocrinol Diabetes. 2000. PMID: 10961352 Review.
[Low-dose oral contraception and bone density].
Karck U, Breckwoldt M. Karck U, et al. Ther Umsch. 2001 Sep;58(9):547-51. doi: 10.1024/0040-5930.58.9.547. Ther Umsch. 2001. PMID: 11594153 Review. German.
Benefits and risks of hormone replacement therapy (HRT).
Breckwoldt M, Keck C, Karck U. Breckwoldt M, et al. Among authors: karck u. J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):205-8. doi: 10.1016/0960-0760(95)00047-4. J Steroid Biochem Mol Biol. 1995. PMID: 7626455 Review.
[Physiology of ovarian function].
Karck U, Keck C. Karck U, et al. Ther Umsch. 2002 Apr;59(4):153-8. doi: 10.1024/0040-5930.59.4.153. Ther Umsch. 2002. PMID: 12018032 German.
Impact of early antibiotic exposure on the risk of colonization with potential pathogens in very preterm infants: a retrospective cohort analysis.
Bubser C, Liese J, Serna-Higuita LM, Müller A, Vochem M, Arand J, Karck U, Gross M, Poets CF, Härtel C, Zemlin M, Gille C, Köstlin-Gille N. Bubser C, et al. Among authors: karck u. Antimicrob Resist Infect Control. 2022 May 19;11(1):72. doi: 10.1186/s13756-022-01110-1. Antimicrob Resist Infect Control. 2022. PMID: 35590392 Free PMC article.
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.
Vergote I, Scambia G, O'Malley DM, Van Calster B, Park SY, Del Campo JM, Meier W, Bamias A, Colombo N, Wenham RM, Covens A, Marth C, Raza Mirza M, Kroep JR, Ma H, Pickett CA, Monk BJ; TRINOVA-3/ENGOT-ov2/GOG-3001 investigators. Vergote I, et al. Lancet Oncol. 2019 Jun;20(6):862-876. doi: 10.1016/S1470-2045(19)30178-0. Epub 2019 May 7. Lancet Oncol. 2019. PMID: 31076365 Free article. Clinical Trial.
36 results